IQVIA Holdings Inc.

NYSE:IQV

Medical - Diagnostics & Research

Healthcare
$257.84 -1.83%

-$3.13 today

Market cap
$42.49B
Beta
1.22
P/E (TTM)
20.4
EPS (TTM)
$8.22
52W Low $153.01High $247.05

Volume 1.40M

Average 1.62M

IQV EBITDA Margin

EBITDA as a percentage of revenue.

IQVIA Holdings Inc.NYSE: IQV

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin narrows to 18.1%

EBITDA Margin was 18.1% in Q2 FY2026, down 1.4 pp from a year earlier. On a trailing-twelve-month basis it was 20.8%, down 0.6 pp year over year. Over 3 fiscal years it narrowed by 2.2 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 14 analysts of 22.9% for the fiscal year ending Dec 2026, up from 18.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
18.1%-1.4 pp QoQ
Last fiscal yearDec 2025
18.0%-4.4 pp YoY
LTMJun 2026
20.8%-0.6 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.4 pp+5.1 pp+6.5 pp
1 year-4.4 pp+4.8 pp+9.2 pp
3 years-2.2 pp+4.9 pp+7.1 pp
5 years+6.3 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
18.0%
Year-over-year change
-4.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How IQV compares with its peers on the latest reported figures

  • IQV's LTM Jun 2026 EBITDA Margin of 20.8% is the 4th highest of the 9 companies compared; the peer median is 10.3%.
  • Its year-over-year change of -0.6 pp is the 5th highest of 9, against a peer median of +0.2 pp.
  • Over three fiscal years its change of -2.2 pp compares with a peer median of -6.0 pp.
IQV Competitors Peer median
EBITDA Margin for IQV and competitors
Company Period LTM level YoY 3-year change
VEEVVeeva Systems Inc.LTM Jul 202639.7% +3.0 pp+14.0 pp
CERTCertara, Inc.LTM Mar 202624.1% +9.7 pp-6.5 pp
MEDPMedpace Holdings, Inc.LTM Sep 202622.7% -0.6 pp+1.4 pp
IQVIQVIA Holdings Inc.LTM Jun 202620.8% -0.6 pp-2.2 pp
ICLRICON Public Limited CompanyLTM Jun 202615.1% -1.9 pp-7.7 pp
CRLCharles River Laboratories International, Inc.LTM Jun 20265.5% -7.6 pp-14.6 pp
FTREFortrea Holdings Inc.LTM Jun 20263.0% +34.4 pp-39.8 pp
TEMTempus AI, Inc.LTM Sep 2026-7.2% +1.0 pp+64.5 pp
HCATHealth Catalyst, Inc.LTM Mar 2026-63.6% -59.1 pp-5.5 pp
Peer median (excluding IQV) 10.3%+0.2 pp-6.0 pp

Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.87B14.41B14.98B15.41B16.31B
Cost of Revenue9.23B9.38B9.75B10.03B10.88B
Gross Profit4.64B5.03B5.24B5.38B5.43B
Gross Margin33.5%34.9%35.0%34.9%33.3%
Research & Development00000
Selling, General & Admin1.96B2.07B2.05B1.99B1.99B
Operating Expenses3.25B3.23B3.26B3.17B3.25B
Depreciation & Amortization1.26B1.13B1.13B1.11B640M
EBITDA2.77B2.91B3.26B3.45B2.94B
EBITDA Margin19.9%20.2%21.7%22.4%18.0%
Operating Income1.39B1.8B1.98B2.2B2.18B
Operating Margin10.0%12.5%13.2%14.3%13.4%
Interest Income6M13M36M47M45M
Interest Expense375M416M672M670M729M
Other Income / Expenses(259M)(448M)(518M)(533M)(569M)
Income Before Tax1.13B1.35B1.46B1.67B1.61B
Pre-Tax Margin8.2%9.4%9.7%10.8%9.9%
Income Tax Expense163M260M101M296M252M
Net Income966M1.09B1.36B1.37B1.36B
Net Margin7.0%7.6%9.1%8.9%8.3%
EPS (Basic)5.055.827.397.577.91
EPS (Diluted)4.955.727.297.497.84
Weighted Avg Shares191.4M187.6M183.8M181.3M171.9M
Weighted Avg Shares (Diluted)195M190.6M186.3M183.4M173.5M

IQVIA Holdings Inc.

NYSE:IQV

Intrinsic Alpha fair value

Locked

Current Price

$257.84

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.